SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003113
Filing Date
2021-11-04
Accepted
2021-11-04 16:58:22
Documents
84
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20210930.htm   iXBRL 10-Q 4016758
2 EX-10.2 dvax-ex10_2.htm EX-10.2 281779
3 EX-10.3 dvax-ex10_3.htm EX-10.3 199087
4 EX-31.1 dvax-ex31_1.htm EX-31.1 16165
5 EX-31.2 dvax-ex31_2.htm EX-31.2 15859
6 EX-32.1 dvax-ex32_1.htm EX-32.1 10381
7 EX-32.2 dvax-ex32_2.htm EX-32.2 10750
  Complete submission text file 0000950170-21-003113.txt   14993296

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20210930_pre.xml EX-101.PRE 493967
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20210930_lab.xml EX-101.LAB 628919
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20210930_cal.xml EX-101.CAL 72161
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20210930_def.xml EX-101.DEF 333563
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20210930.xsd EX-101.SCH 79104
13 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20210930_htm.xml XML 3196226
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 211380917
SIC: 2834 Pharmaceutical Preparations